Literature DB >> 12443613

Hallmarks of cancer progression in Barrett's oesophagus.

Carmela P Morales1, Rhonda F Souza, Stuart J Spechler.   

Abstract

CONTEXT: Hanahan and Weinberg proposed in 200 that carcinogenesis involves DNA changes that enable cells to:provide their own growth signals, ignore growth-inhibitory signals, avoid apoptosis, replicate without limit, sustain angiogenesis, and invade and proliferate in unnatural locations. The metaplastic cells of Barrett's oesophagus are predisposed to develop these cancer hallmarks. STARTING POINT: The genetic changes that have been described in Barrett's oesophagus can be categorised according to the predominant cancer hallmark affected. For example, M Auvinen and colleagues recently observed abnormalities in the expression of vascular endothelial growth factors (VEGFs) in Barrett's oesophagus (J Clin Oncol 2002; 20: 2971-79). These abnormalities can be categorised as those that affect angiogenesis, a process that is essential for the development and progression of tumours. WHERE NEXT? The cancer hallmarks of Barrett's oesophagus provide a framework to categorise the genetic abnormalities described and to further understanding of the genetic events that underlie oesophageal carcinogenesis.

Entities:  

Mesh:

Year:  2002        PMID: 12443613     DOI: 10.1016/S0140-6736(02)11569-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?

Authors:  Evanthia Zampeli; George Karamanolis; George Morfopoulos; Elias Xirouchakis; Vasiliki Kalampoki; Spyros Michopoulos; Sotiria Savva; Vasilios Tzias; Irene Zouboulis-Vafiadis; Dimitrios Kamberoglou; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Radiofrequency ablation for dysplasia in Barrett's esophagus restores β-catenin activation within esophageal progenitor cells.

Authors:  K Krishnan; S Komanduri; J Cluley; R Dirisina; P Sinh; Jeff Z Ko; L Li; R B Katzman; T A Barrett
Journal:  Dig Dis Sci       Date:  2011-09-24       Impact factor: 3.199

Review 3.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 4.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

5.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

6.  Randomized comparison of 3 different-sized biopsy forceps for quality of sampling in Barrett's esophagus.

Authors:  Susana Gonzalez; Woojin M Yu; Michael S Smith; Kristen N Slack; Heidrun Rotterdam; Julian A Abrams; Charles J Lightdale
Journal:  Gastrointest Endosc       Date:  2010-11       Impact factor: 9.427

Review 7.  Potent gastric acid inhibition in the management of Barrett's oesophagus.

Authors:  Angel Lanas
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort.

Authors:  L Murray; A Sedo; M Scott; D McManus; J M Sloan; L J Hardie; D Forman; C P Wild
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

9.  Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.

Authors:  Da-Min Chai; Zheng-Qi Bao; Jian-Guo Hu; Li Ma; Zhen-Zhong Feng; Yi-Sheng Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

Review 10.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.